Showing 63,841 - 63,860 results of 98,751 for search '(( 5 ((step decrease) OR (teer decrease)) ) OR ( 5 ((a decrease) OR (nn decrease)) ))', query time: 0.92s Refine Results
  1. 63841

    Optimizing the plastic injection molding process and reducing warpage through response surface methodology by Van-Long Trinh (21338532)

    Published 2025
    “…This paper demonstrates a method to reduce warpage during IMP by using a response surface methodology (RSM). …”
  2. 63842
  3. 63843
  4. 63844

    Functional effect of the Hsa-miR-185* on the <i>TrkB-T1</i> 3′UTR sequence in HEK 293 cell line. by Gilles Maussion (156014)

    Published 2012
    “…<p>A: Schematic representation of <i>TrkB-T1</i> 3′UTR sequence including the five putative binding sites for Hsa-miR-185*. …”
  5. 63845
  6. 63846
  7. 63847
  8. 63848
  9. 63849
  10. 63850
  11. 63851
  12. 63852
  13. 63853
  14. 63854

    <i>apol1</i> morphant zebrafish embryos display generalized edema and glomerular filtration defects indicative of nephropathy. by Blair R. Anderson (765261)

    Published 2015
    “…<p>Representative live images of (A) sham-injected control larvae, and (B) <i>apol1</i> morpholino (MO) injected larvae at 5 dpf. …”
  15. 63855

    Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  16. 63856

    Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  17. 63857
  18. 63858

    Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  19. 63859

    Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  20. 63860

    Other symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”